Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis

Código QR

Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis

Guardado en:

Detalles Bibliográficos
Autores principales:	Yanqiao Wu, Nagaraja Sreeharsha, Sanjay Sharma, Anurag Mishra, Avinash Kumar Singh, Shiva Kumar Gubbiyappa
Formato:	article
Lenguaje:	EN
Publicado:	American Chemical Society 2020
Materias:	Chemistry QD1-999
Acceso en línea:	https://doaj.org/article/8d56a54130d74e4bb2e0c67ecb833344
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
por: Li-Song Zhang, et al.
Publicado: (2012)

Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ.
por: Kumar Nikhil, et al.
Publicado: (2014)

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Shadi Esmaeili, et al.
Publicado: (2021)

Carvacrol and PPARγ agonist, pioglitazone, affects inhaled paraquat-induced lung injury in rats
por: Fatemeh Amin, et al.
Publicado: (2021)

PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.
por: Lena Serghides, et al.
Publicado: (2014)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
por: Divya P. Kumar, et al.
Publicado: (2020)

Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?
por: Juan M Zolezzi, et al.
Publicado: (2013)

Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
por: Min Hi Park, et al.
Publicado: (2013)

PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings.
por: Monica Puligheddu, et al.
Publicado: (2013)

Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
por: Manav Korpal, et al.
Publicado: (2017)

Defining a conformational ensemble that directs activation of PPARγ
por: Ian M. Chrisman, et al.
Publicado: (2018)

PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow.
por: Shruti Sharma, et al.
Publicado: (2012)

Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1α.
por: Rosario Pardo, et al.
Publicado: (2011)

Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
por: Tsuneyuki Miyazaki, et al.
Publicado: (2021)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors
por: Natacha Rochel, et al.
Publicado: (2019)

Molecular determinants of magnolol targeting both RXRα and PPARγ.
por: Haitao Zhang, et al.
Publicado: (2011)

A molecular switch regulating transcriptional repression and activation of PPARγ
por: Jinsai Shang, et al.
Publicado: (2020)

Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
por: Manav Korpal, et al.
Publicado: (2019)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza MA, et al.
Publicado: (2020)

A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Richard Brust, et al.
Publicado: (2018)

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
por: Qian-Wen Zheng, et al.
Publicado: (2021)

Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection.
por: Zeinab Abdullah, et al.
Publicado: (2012)

Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
por: Zhiyuan Niu, et al.
Publicado: (2017)

Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
por: Zahra Heidari, et al.
Publicado: (2019)

Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
por: Matteo Zanardelli, et al.
Publicado: (2014)

Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances
por: Guoxiu Yan, et al.
Publicado: (2017)

Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
por: Sih-Pei Chen, et al.
Publicado: (2021)

MiRNA-130a promotes inflammation to accelerate atherosclerosis via the regulation of proliferator-activated receptor γ (PPARγ) expression
por: Fengtong Liu, et al.
Publicado: (2021)

Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists.
por: Kylie R Dunning, et al.
Publicado: (2014)

NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
por: Peipei Luan, et al.
Publicado: (2019)

Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
por: Wan R, et al.
Publicado: (2019)

WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity
por: Nathalie Ferrand, et al.
Publicado: (2017)

Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ
por: Hua Mao, et al.
Publicado: (2017)

Carcinogenesis

Cocaine-mediated circadian reprogramming in the striatum through dopamine D2R and PPARγ activation
por: Karen Brami-Cherrier, et al.
Publicado: (2020)

Soy milk and ginger (Sulehe) increase PPAR-γ expression in a rat model of insulin resistance
por: Wiwik Handayani, et al.
Publicado: (2018)

A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion
por: Yuwei Jiang, et al.
Publicado: (2017)

RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network
por: Kyeongkyu Kim, et al.
Publicado: (2017)

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
por: Gloria Brusotti, et al.
Publicado: (2017)

PPARγ controls Dectin-1 expression required for host antifungal defense against Candida albicans.
por: Amandine Galès, et al.
Publicado: (2010)